Your browser doesn't support javascript.
loading
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.
Visvikis-Siest, Sophie; Gorenjak, Vesna; Stathopoulou, Maria G; Petrelis, Alexandros M; Weryha, Georges; Masson, Christine; Hiegel, Brigitte; Kumar, Satish; Barouki, Robert; Boerwinkle, Eric; Dagher, Georges; Deloukas, Panagiotis; Innocenti, Federico; Lamont, John; Marschler, Michael; Meyer, Heiko; Meyer, Urs A; Nofziger, Charity; Paulmichl, Markus; Vacher, Cora; Webster, Lynn.
Afiliação
  • Visvikis-Siest S; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. sophie.visvikis-siest@inserm.fr.
  • Gorenjak V; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. vesna.gorenjak@inserm.fr.
  • Stathopoulou MG; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. maria.stathopoulou@inserm.fr.
  • Petrelis AM; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. apetrelis@live.com.
  • Weryha G; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. g.weryha@chru-nancy.fr.
  • Masson C; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. christine.masson@univ-lorraine.fr.
  • Hiegel B; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. brigitte.hiegel@univ-lorraine.fr.
  • Kumar S; Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. satish.kumar@univ-lorraine.fr.
  • Barouki R; INSERM UMR-S 1124, Université Paris Descartes, Université Sorbonne Paris Cité, 75270 Paris, France. robert.barouki@parisdescartes.fr.
  • Boerwinkle E; Service de Biochimie Métabolomique et Protéomique, Hôpital Universitaire Necker Enfants Malades, AP-HP, 75015 Paris, France. robert.barouki@parisdescartes.fr.
  • Dagher G; Department of Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX 77030, USA. Eric.Boerwinkle@uth.tmc.edu.
  • Deloukas P; Inserm UMR-S 1124, Paris-Descartes University, 75270 Paris, France. georges.dagher@inserm.fr.
  • Innocenti F; Department of Clinical Pharmacology, Queen Mary University of London, London E1 4NS, UK. p.deloukas@qmul.ac.uk.
  • Lamont J; Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599-2200, USA. innocent@email.unc.edu.
  • Marschler M; Randox Laboratories Ltd., Crumlin, County Antrim BT29 4XL, UK. john.lamont@randox.com.
  • Meyer H; PRAHealthSciences, 68165 Mannheim, Germany. marschlermichael@prahs.com.
  • Meyer UA; Agena Bioscience GmbH, 22761 Hamburg, Germany. heiko.meyer@agenabio.com.
  • Nofziger C; Biozentrum, University of Basel, 4056 Basel, Switzerland. urs-a.meyer@unibas.ch.
  • Paulmichl M; PharmGenetix Gmbh, 1090 Vienna, Austria. charity.nofziger@pharmgenetix.com.
  • Vacher C; Center for Health & Bioresources, Austrian Institute of Technology, 1210 Vienna, Austria. paulmichl@me.com.
  • Webster L; NESMOS Department, University of Rome Sapienza, 00185 Rome, Italy. paulmichl@me.com.
J Pers Med ; 8(4)2018 12 12.
Article em En | MEDLINE | ID: mdl-30545130
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article